Effect of a two-dose vs three-dose vaccine strategy in residential colleges using an empirical proximity network.
Hambridge HL, Kahn R, Onnela JP.
Int J Infect Dis. 2022 Apr 08. 119:210-213. PMID: 35405350
Links
Overview
Rebecca Kahn is a Postdoctoral Research Fellow in the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health. After graduating with a BA in Public Policy and Global Health from Duke University, she worked with PEPFAR in the U.S. State Department Office of the Global AIDS Coordinator. She then worked for Partners In Health in Sierra Leone on the Ebola response and health systems strengthening programs. She earned her MS in Epidemiology in 2018 and her PhD in Population Health Sciences and Epidemiology in 2020 from Harvard. Her research focuses on using infectious disease modeling to enhance epidemic preparedness and response.
BA, 05/2013, Public Policy & Global Health
Duke University
MS, 05/2018, Epidemiology
Harvard University
PhD, 11/2020, Population Health Sciences & Epidemiology
Harvard University
Bibliography
Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines.
Kahn R, Schrag SJ, Verani JR, Lipsitch M.
Am J Epidemiol. 2022 Mar 24. 191(5):800-811. PMID: 35081612
Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes.
Kahn R, Holmdahl I, Reddy S, Jernigan J, Mina MJ, Slayton RB.
Clin Infect Dis. 2022 03 01. 74(4):597-603. PMID: 34086877
Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
Holmdahl I, Kahn R, Slifka KJ, Dooling K, Slayton RB.
Clin Infect Dis. 2022 Jan 29. PMID: 35092678
Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design.
Greene SK, Levin-Rector A, McGibbon E, Baumgartner J, Devinney K, Ternier A, Sell J, Kahn R, Kishore N.
Vaccine X. 2022 Apr. 10:100134. PMID: 34961848
Correction: Practical considerations for measuring the effective reproductive number, Rt.
Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday JD, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S.
PLoS Comput Biol. 2021 Dec. 17(12):e1009679. PMID: 34879070
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.
Bushman M, Kahn R, Taylor BP, Lipsitch M, Hanage WP.
Cell. 2021 12 22. 184(26):6229-6242.e18. PMID: 34910927
Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load.
Kennedy-Shaffer L, Kahn R, Lipsitch M.
Epidemiology. 2021 11 01. 32(6):820-828. PMID: 34469363
Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
Holmdahl I, Kahn R, Slifka KJ, Dooling K, Slayton RB.
medRxiv. 2021 Oct 26. PMID: 34729570
Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network.
Hambridge HL, Kahn R, Onnela JP.
Int J Infect Dis. 2021 Dec. 113:325-330. PMID: 34624516
News
Infectious diseases modeler Rebecca Kahn named STAT Wunderkind
Rebecca Kahn, visiting scientist and former postdoctoral research fellow in the Center for Communicable Disease Dynamics, was named a 2021 STAT Wunderkind in mid-November.
Epidemiologists Marc Lipsitch and Rebecca Kahn to help establish new CDC center
Harvard Chan School's Marc Lipsitch and Rebecca Kahn will help establish a new CDC center focused on epidemic forecasting and outbreak analytics.
